Title : Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line.

Pub. Date : 2019 Aug

PMID : 31078602






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line. Erlotinib Hydrochloride AKT1 substrate 1 Homo sapiens